Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Efgartigimod”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06558279
What this trial is testing

Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Ocular
argenx 141
Post-approval studies (Phase 4)Study completedNCT06637072
What this trial is testing

Assess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SC

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
argenx 23
Large-scale testing (Phase 3)Active Not RecruitingNCT05523167
What this trial is testing

Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

Who this might be right for
Active Idiopathic Inflammatory MyopathyMyositisDermatomyositis+3 more
argenx 265
Post-approval studies (Phase 4)Looking for participantsNCT06909214
What this trial is testing

Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)

Who this might be right for
New Onset Generalized Myasthenia Gravis (gMG)
argenx 30
Testing effectiveness (Phase 2)Study completedNCT05633407
What this trial is testing

Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS

Who this might be right for
Postural Orthostatic Tachycardia Syndrome
argenx 53
Not applicableNot Yet RecruitingNCT07079020
What this trial is testing

Efgartigimod for Consolidation Therapy in gMG

Who this might be right for
Myasthenia Gravis
Da, Yuwei, M.D. 130
Testing effectiveness (Phase 2)Study completedNCT06203457
What this trial is testing

Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome

Who this might be right for
Primary Sjögren's Syndrome
argenx 24
Large-scale testing (Phase 3)Looking for participantsNCT06544499
What this trial is testing

Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
argenx 69
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07011589
What this trial is testing

Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)

Who this might be right for
Epidermolysis Bullosa (EB)Epidermolysis Bullosa AcquisitaRecessive Dystrophic Epidermolysis Bullosa+1 more
M. Peter Marinkovich 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07583641
What this trial is testing

Learn About How Well the Medicine Efgartigimod Works to Treat Autoimmune Encephalitis In Children 12 Years or Older and Adults

Who this might be right for
Autoimmune Encephalitis (AE)
argenx 170
Large-scale testing (Phase 3)Study completedNCT04818671
What this trial is testing

Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
argenx 184
Large-scale testing (Phase 3)Not Yet RecruitingNCT06885762
What this trial is testing

Efgartigimod for the Treatment of Guillain-Barré Syndrome

Who this might be right for
Guillain-Barre Syndrome (GBS)
Zhongming Qiu 20
Large-scale testing (Phase 3)Enrolling By InvitationNCT05374590
What this trial is testing

Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisgMG
argenx 12
Large-scale testing (Phase 3)Study completedNCT04598451
What this trial is testing

Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)

Who this might be right for
Pemphigus VulgarisPemphigus Foliaceus
argenx 222
Testing effectiveness (Phase 2)Looking for participantsNCT07025330
What this trial is testing

Efgartigimod in Patients With IgG4-Related Disease

Who this might be right for
IgG4-related Disease
Stanford University 5
Large-scale testing (Phase 3)WithdrawnNCT04274452
What this trial is testing

Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
argenx
Large-scale testing (Phase 3)Study completedNCT04980495
What this trial is testing

An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisMG - Myasthenia GravisgMG
argenx 69
Large-scale testing (Phase 3)Ended earlyNCT04598477
What this trial is testing

Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)

Who this might be right for
Pemphigus VulgarisPemphigus Foliaceus
argenx 183
Testing effectiveness (Phase 2)Study completedNCT05810948
What this trial is testing

Assess Effectiveness and Safety of Efgartigimod in Chinese Patients With Lupus Nephritis (ZL-1103-013)

Who this might be right for
Lupus Nephritis
argenx 73
Not applicableAvailableNCT04777734
What this trial is testing

Pre-Approval Access for Efgartigimod PH20 SC in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)CIDP
argenx
Load More Results